Funds and ETFs Melodiol Global Health Limited

Equities

ME1

AU0000282840

Pharmaceuticals

Market Closed - Australian S.E. 02:10:45 2024-04-26 am EDT 5-day change 1st Jan Change
0.003 AUD -25.00% Intraday chart for Melodiol Global Health Limited -33.33% -92.50%
Melodiol Global Health Limited, formerly Creso Pharma Limited, is an Australia-based cannabis company. The Company is engaged in developing cannabis and hemp-derived therapeutic-grade nutraceuticals and medical cannabis products with a range of applications in both human and animal health. Its cannabidiol (CBD) plant-based nutraceutical products are non-psychoactive, as they only contain trace amounts of tetrahydrocannabinol (THC). Its product is offered under various brands, including Green Goo, Southern Butter, Good Goo, Ritual, impactive and cannaQIX, among others. It cultivates and harvests cannabis plants through its subsidiary, Mernova Medicinal Inc. and supplies cannabis retail products throughout Canada. Through its wholly owned, Canada-based psychedelics subsidiary, Halucenex Life Sciences Inc., it is also focused on the development of synthetic and botanical psilocybin treatments for treatment-resistant post-traumatic stress disorder, and other mental health conditions.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. ME1 Stock
  4. Funds and ETFs Melodiol Global Health Limited